· Mild BP reduction (SBP ↓10-15 mmHg) with bidirectional stabilization of vascular tension
· Non-pharmacological adjunct to antihypertensive drugs (e.g., ACE inhibitors)
Vascular Adaptation:
· Enhanced endothelial function via cyclic ischemia-reperfusion
· Reduced peripheral resistance through smooth muscle relaxation
Biochemical Modulation:
· NO-mediated vasodilation
· Attenuated blood pressure variability
Not a standalone treatment – Must combine with:
· Real-time BP monitoring (device-recorded trends)
· Personalized intensity adjustment (per physician guidance)
· Continued pharmacotherapy (e.g., ACEI/ARB maintenance)